A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy

by Xun Wu, Xingsheng Hu, Junru Chen, Lang He
Published 2021-06-01

Recombinant Human Endostatin in the Treatment of Advanced Lung Squamous Cell Carcinoma

by Puyuan XING, Xuezhi HAO, Xingsheng HU, Yan WANG, Junling LI
Published 2016-10-01

Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer

by Yan PENG, Yan WANG, Junling LI, Xuezhi HAO, Xingsheng HU
Published 2016-09-01

Prognostic Value of MACC1 and c-met Expressions in Non-small Cell Lung Cancer

by Xingsheng HU, Xi FU, Shimin WEN, Xinyi ZOU, Yusong LIU
Published 2012-07-01

Efficacy and safety profile of combining programmed cell death‐1 (PD‐1) inhibitors and antiangiogenic targeting agents as subsequent therapy for advanced or metastatic non‐small ce...

by Ziyi Xu, Teng Li, Xingsheng Hu, Xuezhi Hao, Puyuan Xing, Junling Li
Published 2021-09-01

Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China

by Xingsheng Hu, Chunhong Hu, Yong Yang, Juan Chen, Ping Zhong, Yajing Wen, Xiangyu Chen
Published 2020-10-01

Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China

by Xingsheng Hu, Chunhong Hu, Dixuan Jiang, Qian Zuo, Ya Li, Yang Wang, Xiangyu Chen
Published 2020-12-01

Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China

by Xingsheng Hu, Chunhong Hu, Ping Zhong, Yajing Wen, Yong Yang, Juan Chen, Xiangyu Chen
Published 2020-08-01

Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

by Xingsheng Hu, Ke Pu, Xuqin Feng, Shimin Wen, Xi Fu, Cuihua Guo, Wenwu He
Published 2016-01-01

Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.

by Xingsheng Hu, Wenwu He, Shimin Wen, Xuqin Feng, Xi Fu, Yusong Liu, Ke Pu
Published 2016-01-01

A Retrospective Study of the Efficacy and Toxicity of Irinotecan in Combination with Nedaplatin versus Irinotecan in Combination with Cisplatin as Salvage
Treatment in Refractory o...

by Shufei YU, Yan WANG, Xingsheng HU, Hongyu WANG, Xuezhi HAO, Jianping XU, Junling LI, Xiangru ZHANG, Yuankai SHI
Published 2013-09-01

Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma

by Shouzheng Wang, Tongji Xie, Xuezhi Hao, Yan Wang, Xingsheng Hu, Lin Wang, Yan Li, Junling Li, Puyuan Xing
Published 2021-10-01

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

by Xingsheng Hu, Xin Zheng, Sheng Yang, Lin Wang, Xuezhi Hao, Xinge Cui, Lieming Ding, Li Mao, Pei Hu, Yuankai Shi
Published 2020-01-01

Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation 
in Advanced Lung Adenocarcinoma

by Yutao LIU, Yuankai SHI, Xingsheng HU, Xuezhi HAO, Junling LI, Ziping WANG, Yan WANG, Hongyu WANG, Xiangru ZHANG, Yan SUN
Published 2014-05-01

Population Pharmacokinetics and Exposure–Safety Relationship of Paclitaxel Liposome in Patients With Non-small Cell Lung Cancer

by Haiyan Zhou, Jiaqing Yan, Wei Chen, Jun Yang, Min Liu, Yuan Zhang, Xin Shen, Yinglin Ma, Xingsheng Hu, Yan Wang, Kehe Du, Guohui Li
Published 2021-02-01

Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma

by Ping HE, Yan WANG, Sheng YANG, Shufei YU, Ziping WANG, Junling LI, Bin WANG, Xuezhi HAO, Hongyu WANG, Xingsheng HU, Xiangru ZHANG, Yuankai SHI
Published 2013-10-01

Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Populatio...

by Xiaohong Han, Zhishang Zhang, Di Wu, Yinchen Shen, Shuai Wang, Lin Wang, Yutao Liu, Sheng Yang, Xingsheng Hu, Yun Feng, Yan Sun, Yuankai Shi
Published 2014-12-01

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer

by Sheng YANG, Yan WANG, Xingsheng HU, Hongyu WANG, Xuezhi HAO, Jianping XU, Lin WANG, Bin WANG, Junling LI, Longmei ZHAO, Peidi JIANG, Fenglian QU, Xiangru ZHANG, Yuankai SHI
Published 2016-05-01

Efficacy and Toxicity of Pemetrexed or Gemcitabine Combined with Cisplatin in the Treatment of Patients with Advanced Non-small Cell Lung Cancer

by Xingsheng HU, Shunchang JIAO, Shucai ZHANG, Zhehai WANG, Mengzhao WANG, Cheng HUANG, Rongsheng ZHENG, Kai LI, Jie WANG, Yajie WANG, Xuenong OUYANG, Wenguang LV, Gang CHENG, Chunhong HU, Rongcheng LUO, Yan SUN
Published 2012-10-01

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

by Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu, Chengping Hu
Published 2020-05-01